Unlicensed Use
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
ABSTRACT This study was designed to investigate the use of off-label and unlicensed drugs in a Neonatal Care Unit (NCU) and to compare the frequency of use of off-label drugs according to the drug regulatory agencies in Brazil (Agência Nacional de Vigilância Sanitária-ANVISA) and the United States Food and Drug Administration (FDA). A prospective observat
Braz. J. Pharm. Sci.. Publicado em: 01/02/2018
-
2. Avaliação em Música: um estudo sobre o relato das práticas avaliativas de uma amostra de professores de música em quatro contextos de ensino em Salvador - Bahia.
The present study investigated the assessment practices of music teachers in Salvador who work in public and private schools, specialized music schools and NGOs. Data collection was through questionnaires and semi-structured interviews. The study sought to understand, analyze and interpret the concept of teachers on assessment in music, as well as their prac
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/12/2010
-
3. The use of unlicensed and off label medicines for children admitted to the neonatal intensive care unit of a median complexity university Hospital in São Paulo / Perfil da utilização de medicamentos não licenciados e sem indicação para crianças em UTI neonatal de Hospital Universitário de média complexidade
Introduction. In pediatrics utilization of unlicensed an off-label drugs are a common practice and this account for ethical and economic reasons. The utilization of unlicensed and off label drugs is not illegal, but can expose patients to risk of harm. Physicians and pharmacists have legal responsibility for any adverse event that may result from this use. S
Publicado em: 2009
-
4. Medicamentos potencialmente perigosos, não aprovados e de uso off label em prescrições pediátricas de um hospital universitário / High-alert medications, unlicensed and off label use in pediatric prescriptions of a university hospital in southern Brazil
Objetivos: Descrever o uso e determinar a prevalência de medicamentos potencialmente perigosos e de uso off label e não aprovados em prescrições de unidades de pediatria geral de um hospital universitário no sul do Brasil. Método: Estudo transversal, realizado de novembro de 2007 a janeiro de 2008, envolvendo pacientes até 14 anos de idade, com perío
Publicado em: 2009
-
5. Survey of unlicensed and off label drug use in paediatric wards in European countries
British Medical Journal.
-
6. Unlicensed and off label drug use by children in the community: cross sectional study
BMJ.
-
7. Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
Two new drugs provide startling benefits in the treatment of age‐related macular degeneration (AMD). The clinical and cost effectiveness of ranibizumab (Lucentis) was compared to that of bevacizumab (Avastin), which costs up to 100 times less. A cost effectiveness model was developed to assess the cost per quality adjusted life year (QALY) over 10 years.
BMJ Group.